Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Crit Care Med. 2022 Feb 7;50(6):924–934. doi: 10.1097/CCM.0000000000005470

Figure 2. Immune Outcomes.

Figure 2.

This figure details the differences in immune parameters between the therapeutic hyperthermia (Warming) and usual care (Control) groups. All bars show the mean value for each group, and the error bars represent the standard deviation. A. HLA-DR expression. B. Lymphopenia observed on each day of observation (among participants who had an absolute lymphocyte count recorded on any given day. C. IFN-γ spot number (representing number of cells producing IFN-γ). D. IFN-γ spot area. HLA, human leukocyte antigen; IFN, interferon; SFU, spot-forming unit.